Document Detail

Assessment of gastric antisecretory effects of phenoxyisobutyrate derivatives in the rat and the mouse.
MedLine Citation:
PMID:  3247588     Owner:  NLM     Status:  MEDLINE    
After the observation of a low incidence of gastric carcinoid tumours in rats, but not in mice, given ciprofibrate for 2 years, ciprofibrate and related compounds were investigated for gastric antisecretory activity. A significant inhibition of gastric secretion, similar to that induced by comparable doses of cimetidine, was observed in the fischer rat 1.5 h after a single oral (200 or 500 mg kg-1) or intraduodenal (100 or 300 mg kg-1) administration of ciprofibrate, bezafibrate, and clofibric acid. Ciprofibrate had prolonged antisecretory activity when compared with bezafibrate or ranitidine. Prolonged inhibition of gastric secretion is proposed as the primary cause of gastric carcinoids in the rat, since in a comparative evaluation, antisecretory activity was observed in the rat but not in the mouse.
C T Eason; A Pattison; D D Howells; A J Spencer; F W Bonner
Related Documents :
9605258 - A rat model of chronic helicobacter pylori infection. studies of epithelial cell turnov...
9641298 - Oral human spasmolytic polypeptide protects against aspirin-induced gastric injury in r...
6272368 - 15-hydroxyprostaglandin dehydrogenase and delta 13 reductase content of gastrointestina...
6376148 - Stimulation of gastric alkaline secretion by stable prostacyclin analogues in rat and dog.
9291508 - Methamidophos: an anticholinesterase without significant effects on postsynaptic recept...
20495898 - Estrogens inhibit food intake in cck-1 receptor-deficient rats.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Scandinavian journal of gastroenterology     Volume:  23     ISSN:  0036-5521     ISO Abbreviation:  Scand. J. Gastroenterol.     Publication Date:  1988 Nov 
Date Detail:
Created Date:  1989-06-20     Completed Date:  1989-06-20     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0060105     Medline TA:  Scand J Gastroenterol     Country:  NORWAY    
Other Details:
Languages:  eng     Pagination:  1063-71     Citation Subset:  IM    
Toxicology Dept., Sterling-Winthrop Research Centre, Alnwick, Northumberland, U.K.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Bezafibrate / pharmacology*
Carcinoid Tumor / chemically induced
Clofibrate / analogs & derivatives*,  pharmacology*
Clofibric Acid / analogs & derivatives*,  pharmacology
Gastric Juice / drug effects,  secretion*
Mice, Inbred Strains
Rats, Inbred F344
Species Specificity
Stomach Neoplasms / chemically induced
Time Factors
Reg. No./Substance:
41859-67-0/Bezafibrate; 52214-84-3/ciprofibrate; 637-07-0/Clofibrate; 882-09-7/Clofibric Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Food intake in relation to pouch volume, stoma diameter, and pouch emptying after gastroplasty for m...
Next Document:  Diagnostic value of ascitic fluid cholesterol levels in the prediction of malignancy.